A report was received on 26 mar 2024 from the home therapy nurse (htn) of a 55 year old male patient with a medical history including end stage renal disease, who stated the patent's blood pressure decreased (nos) which continued to worsen during a home hemodialysis treatment on 19 mar 2024.Treatment was terminated, rinseback was performed, and emergency medical services (ems) were contacted.Per the htn, the patient lost an unspecified amount of blood from an unclamped medication line and they were transported to hospital on (b)(6) 2024.Additional information was received on 27 mar 2024 from the htn stating the patient was admitted for hypotension and received a blood transfusion.Per the htn, the patient was discharged (b)(6) 2024 in stable condition with a diagnosis of convulsive syncope and continues therapy with the nxstage system.
|
No product was received for evaluation.All devices must meet quality requirements and manufacturing specifications prior to release.The instructions for use states "check the system for blood and fluid leaks during treatment, and pay close attention to the blood line and access connections." all treatments must be administered under a physician's prescription and performed by a trained and qualified person, considered to be competent in the use of this device by the prescribing physician so that alarms and harmful conditions can be responded to promptly.
|